Simon Mangcwatywa

Directeur Général chez

Sizwe Medical Fund

Health Technology

Miscellaneous

Profil

Simon Mangcwatywa is currently the Chief Executive Officer at Sizwe Medical Fund since 2018.
Prior to this, he worked as the Medical Director at Adcock Ingram Holdings Ltd., Head-Scientific Operations at Novartis SA, and Head-Medical Affairs & Business Development at Litha Pharma (Pty) Ltd.

Postes actifs de Simon Mangcwatywa

Sociétés	Poste	Début
Sizwe Medical Fund Sizwe Medical Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust	Directeur Général	01/01/2018

Tous les postes actifs de Simon Mangcwatywa

Anciens postes connus de Simon Mangcwatywa

Sociétés	Poste	Fin
Litha Pharma (Pty) Ltd. Litha Pharma (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets, and distributes pharmaceutical and generic products as well as medical devices	Corporate Officer/Principal	-
Novartis SA Novartis SA Pharmaceuticals: MajorHealth Technology Manufactures and markets health care, nutritional and agricultural products	Corporate Officer/Principal	-
ADCOCK INGRAM HOLDINGS LIMITED	Directeur Technique/Scientifique/R&D	-

Voir l'expérience en détail de Simon Mangcwatywa

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Simon Mangcwatywa

Sociétés liées

Entreprise privées	4
Novartis SA Novartis SA Pharmaceuticals: MajorHealth Technology Manufactures and markets health care, nutritional and agricultural products	Health Technology
Adcock Ingram Holdings Ltd. Adcock Ingram Holdings Ltd. Pharmaceuticals: MajorHealth Technology Manufactures, markets & sells branded and generic prescription and over-the-counter pharmaceutical	Health Technology
Litha Pharma (Pty) Ltd. Litha Pharma (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets, and distributes pharmaceutical and generic products as well as medical devices	Health Technology
Sizwe Medical Fund Sizwe Medical Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust	Miscellaneous